Multiple RSV strains infecting HEp-2 and A549 cells reveal cell line-dependent differences in resistance to RSV infection
ABSTRACT Respiratory syncytial virus (RSV) is a leading cause of pediatric acute respiratory infection worldwide. There are currently no approved vaccines or antivirals to combat RSV disease. A few transformed cell lines and two historic strains have been extensively used to study RSV. Here we report a thorough molecular and cell biological characterization of HEp-2 and A549 cells infected with four strains of RSV representing both major subgroups as well as historic and more contemporaneous genotypes -- [RSV/A/Tracy (GA1), RSV/A/Ontario (ON), RSV/B/18537 (GB1), RSV/B/Buenos Aires (BA)] -- via measurements of viral replication kinetics and viral gene expression, immunofluorescence-based imaging of gross cellular morphology and cell-associated RSV, and measurements of host response including transcriptional changes and levels of secreted cytokines and growth factors. Our findings strongly suggest 1) the existence of a conserved difference in gene expression between RSV subgroups A and B; 2) the A549 cell line is a more stringent and natural host of replicating RSV than the HEp-2 cell line; and 3) consistent with previous studies, determining the full effects of viral genetic variation in RSV pathogenesis requires model systems as tractable as transformed cell lines but better representative of the human host.IMPORTANCE Infection with respiratory syncytial virus (RSV) early in life is essentially guaranteed and can lead to severe disease. In vitro data from two historic RSV/A strains and two cell lines, HEp-2 and A549, constitute most of our knowledge; but RSV contains ample variation from two evolving subgroups (A and B) showing recent convergent evolution. Here we measure viral action and host response in HEp-2 and A549 cells infected with four RSV strains from both subgroups and representing both historic and more contemporaneous strains. We discover a subgroup-dependent difference in viral gene expression and find A549 cells are more potently antiviral and more sensitive, albeit subtly, to viral variation. Our findings reveal important differences between RSV subgroups and two widely used cell lines and provide baseline data for experiments with model systems better representative of natural RSV infection..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
bioRxiv.org - (2021) vom: 18. Juni Zur Gesamtaufnahme - year:2021 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Rajan, Anubama [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| doi: |
10.1101/2021.06.15.448622 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XBI032017510 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | XBI032017510 | ||
| 003 | DE-627 | ||
| 005 | 20230429094643.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210618s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1101/2021.06.15.448622 |2 doi | |
| 035 | |a (DE-627)XBI032017510 | ||
| 035 | |a (biorXiv)10.1101/2021.06.15.448622 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 570 |q DE-84 | |
| 100 | 1 | |a Rajan, Anubama |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Multiple RSV strains infecting HEp-2 and A549 cells reveal cell line-dependent differences in resistance to RSV infection |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a ABSTRACT Respiratory syncytial virus (RSV) is a leading cause of pediatric acute respiratory infection worldwide. There are currently no approved vaccines or antivirals to combat RSV disease. A few transformed cell lines and two historic strains have been extensively used to study RSV. Here we report a thorough molecular and cell biological characterization of HEp-2 and A549 cells infected with four strains of RSV representing both major subgroups as well as historic and more contemporaneous genotypes -- [RSV/A/Tracy (GA1), RSV/A/Ontario (ON), RSV/B/18537 (GB1), RSV/B/Buenos Aires (BA)] -- via measurements of viral replication kinetics and viral gene expression, immunofluorescence-based imaging of gross cellular morphology and cell-associated RSV, and measurements of host response including transcriptional changes and levels of secreted cytokines and growth factors. Our findings strongly suggest 1) the existence of a conserved difference in gene expression between RSV subgroups A and B; 2) the A549 cell line is a more stringent and natural host of replicating RSV than the HEp-2 cell line; and 3) consistent with previous studies, determining the full effects of viral genetic variation in RSV pathogenesis requires model systems as tractable as transformed cell lines but better representative of the human host.IMPORTANCE Infection with respiratory syncytial virus (RSV) early in life is essentially guaranteed and can lead to severe disease. In vitro data from two historic RSV/A strains and two cell lines, HEp-2 and A549, constitute most of our knowledge; but RSV contains ample variation from two evolving subgroups (A and B) showing recent convergent evolution. Here we measure viral action and host response in HEp-2 and A549 cells infected with four RSV strains from both subgroups and representing both historic and more contemporaneous strains. We discover a subgroup-dependent difference in viral gene expression and find A549 cells are more potently antiviral and more sensitive, albeit subtly, to viral variation. Our findings reveal important differences between RSV subgroups and two widely used cell lines and provide baseline data for experiments with model systems better representative of natural RSV infection. | ||
| 700 | 1 | |a Piedra, Felipe-Andrés |e verfasserin |4 aut | |
| 700 | 1 | |a Aideyan, Letisha |e verfasserin |4 aut | |
| 700 | 1 | |a McBride, Trevor |e verfasserin |4 aut | |
| 700 | 1 | |a Robertson, Matthew |e verfasserin |4 aut | |
| 700 | 1 | |a Johnson, Hannah L. |e verfasserin |4 aut | |
| 700 | 1 | |a Aloisio, Gina Marie |e verfasserin |4 aut | |
| 700 | 1 | |a Henke, David |e verfasserin |4 aut | |
| 700 | 1 | |a Coarfa, Cristian |e verfasserin |4 aut | |
| 700 | 1 | |a Stossi, Fabio |e verfasserin |4 aut | |
| 700 | 1 | |a Menon, Vipin Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Doddapaneni, Harshavardhan |e verfasserin |4 aut | |
| 700 | 1 | |a Muzny, Donna Marie |e verfasserin |4 aut | |
| 700 | 1 | |a Cregeen, Sara Joan Javornik |e verfasserin |4 aut | |
| 700 | 1 | |a Hoffman, Kristi Louise |e verfasserin |4 aut | |
| 700 | 1 | |a Petrosino, Joseph |e verfasserin |4 aut | |
| 700 | 1 | |a Gibbs, Richard A |e verfasserin |4 aut | |
| 700 | 1 | |a Avadhanula, Vasanthi |e verfasserin |4 aut | |
| 700 | 1 | |a Piedra, Pedro A. |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2021) vom: 18. Juni |
| 773 | 1 | 8 | |g year:2021 |g day:18 |g month:06 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1101/2021.06.15.448622 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XBI | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |j 2021 |b 18 |c 06 | ||
| 953 | |2 045F |a 570 | ||